RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Akira Kawamura to Atherosclerosis

This is a "connection" page, showing publications Akira Kawamura has written about Atherosclerosis.
Connection Strength

0.298
  1. Suematsu Y, Kawachi E, Idemoto Y, Matsuo Y, Kuwano T, Kitajima K, Imaizumi S, Kawamura A, Saku K, Uehara Y, Miura SI. Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide. Int J Cardiol. 2019 12 15; 297:111-117.
    View in: PubMed
    Score: 0.154
  2. Kawamura A, Baitsch D, Telgmann R, Feuerborn R, Weissen-Plenz G, Hagedorn C, Saku K, Brand-Herrmann SM, von Eckardstein A, Assmann G, Nofer JR. Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2007 Jul; 27(7):1610-7.
    View in: PubMed
    Score: 0.066
  3. Matsuo Y, Miura S, Kawamura A, Uehara Y, Rye KA, Saku K. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis. 2007 Sep; 194(1):159-68.
    View in: PubMed
    Score: 0.064
  4. Miura S, Matsuo Y, Kawamura A, Saku K. JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27(kip1) and Ras/p21(waf1) pathways. Atherosclerosis. 2005 Oct; 182(2):267-75.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support